Drug firm Alembic Pharmaceuticals on Friday said its arm, Alembic
Global Holding SA, has received approval from the US health regulator
for its generic Treprostinil injection used for the treatment of
pulmonary arterial hypertension.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-global-holding-sa-gets-usfda-nod-for-pulmonary-arterial-hypertension-treatment-injection/articleshow/80879959.cms
No comments:
Post a Comment